NCT03282370View on ClinicalTrials.gov

Evaluate Safety and Immunogenicity of a Vero Cell-Derived JE Vaccine in 9-24 Months of Age Children in Vietnam

PHASE3CompletedINTERVENTIONAL
Enrollment

655

Participants

Timeline

Start Date

September 30, 2017

Primary Completion Date

February 6, 2018

Study Completion Date

April 8, 2018

Conditions
Japanese Encephalitis
Interventions
BIOLOGICAL

JEVAX

JEVAX - VABIOTECH Vietnam Liquid form Subcutaneous injection 0.5ml/dose, 2 doses, 28-34 days interval

BIOLOGICAL

JECEVAX

JECEVAX - VABIOTECH Vietnam Liquid form Composition: 0.5 BR209 Subcutaneous injection 0.5ml/dose, 2 doses, interval 28-34 days

Trial Locations (4)

35000

Hoa Binh City Health Center, Hòa Bình

350000

Hoa Binh Provincial Preventive Medicine Center, Hòa Bình

Unknown

District Health Center, Thanh Sơn

Phu Tho Preventive Medicine Center, Việt Trì

All Listed Sponsors
collaborator

Ministry of Science and Technology, Vietnam

OTHER_GOV

collaborator

Ministry of Health, Vietnam

OTHER_GOV

lead

National Institute of Hygiene and Epidemiology, Vietnam

OTHER

NCT03282370 - Evaluate Safety and Immunogenicity of a Vero Cell-Derived JE Vaccine in 9-24 Months of Age Children in Vietnam | Biotech Hunter | Biotech Hunter